T004 HHSN2610004 Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Immunologic Effects of NSAIDs With and Without a Vaccine in Colon Cancer Prevention

Grant

Date/time Interval

  • September 15, 2015 - September 16, 2021
  • Total Award Amount

  • 922642.00
  • Direct Costs

  • 889710.00
  • Sponsor Award Id

  • HHSN261201500036I-HHSN2610004
  • Contributor

  • Grubbs Ph.D., Clinton   Principal Investigator